8-K Summary: Vera Therapeutics, Inc.

Date: November 5, 2025

Vera Therapeutics (VERA) filed this 8-K reporting the issuance of its Q3 2025 financial results and recent corporate updates via press release (furnished as Exhibit 99.1).

• Material Event: Item 2.02 – Disclosure of Financial Results.
• Key Investor Action: Investors must review Exhibit 99.1 for specific financial metrics, performance details, and any forward-looking guidance for the quarter ended September 30, 2025.
• Regulatory Note: Information furnished herein is not deemed “filed” under Se